These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7114595)
1. Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant. Smookler S; Bermudez AJ Ann Emerg Med; 1982 Sep; 11(9):482-4U. PubMed ID: 7114595 [TBL] [Abstract][Full Text] [Related]
2. Phenylpropanolamine-associated hypertension after the use of "over-the-counter" appetite-suppressant products. McEwen J Med J Aust; 1983 Jul; 2(2):71-3. PubMed ID: 6679050 [TBL] [Abstract][Full Text] [Related]
3. MAOIs and hypertensive crises: the role of OTC drugs. Harrison WM; McGrath PJ; Stewart JW; Quitkin F J Clin Psychiatry; 1989 Feb; 50(2):64-5. PubMed ID: 2464583 [TBL] [Abstract][Full Text] [Related]
5. Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin. Lee KY; Beilin LJ; Vandongen R Lancet; 1979 May; 1(8126):1110-1. PubMed ID: 86834 [TBL] [Abstract][Full Text] [Related]
7. Amphetamine-like reactions to phenylpropanolamine. Dietz AJ JAMA; 1981 Feb; 245(6):601-2. PubMed ID: 7452888 [TBL] [Abstract][Full Text] [Related]
8. Over-the-counter phenylpropanolamine: a possible cause of central retinal vein occlusion. Gilmer G; Swartz M; Teske M; Crandall AS Arch Ophthalmol; 1986 May; 104(5):642. PubMed ID: 3707408 [No Abstract] [Full Text] [Related]
10. Cerebral infarction with a single oral dose of phenylpropanolamine. Edwards M; Russo L; Harwood-Nuss A Am J Emerg Med; 1987 Mar; 5(2):163-4. PubMed ID: 3828020 [TBL] [Abstract][Full Text] [Related]
11. Hypertensive crisis resulting from avocados and a MAO inhibitor. Generali JA; Hogan LC; McFarlane M; Schwab S; Hartman CR Drug Intell Clin Pharm; 1981 Nov; 15(11):904-6. PubMed ID: 7297422 [TBL] [Abstract][Full Text] [Related]
17. Nonprescription appetite suppressants. Drew R N C Med J; 1983 Sep; 44(9):573-4. PubMed ID: 6579375 [No Abstract] [Full Text] [Related]
18. FDA issues public health advisory on phenylpropanolamine in drug products. Meadows M FDA Consum; 2001; 35(1):9. PubMed ID: 11930934 [No Abstract] [Full Text] [Related]
19. Neurological and cardiac events on phenylpropanolamine. Prescrire Int; 1999 Dec; 8(44):181. PubMed ID: 11503819 [TBL] [Abstract][Full Text] [Related]
20. Rhabdomyolysis after ingestion of an appetite suppressant. Rumpf KW; Kaiser HF; Horstkotte H; Bahlmann J JAMA; 1983 Oct; 250(16):2112. PubMed ID: 6620516 [No Abstract] [Full Text] [Related] [Next] [New Search]